- Home
- PLUG vs KROS Comparison
PLUG vs KROS Comparison
Compare PLUG & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- KROS
- Stock Information
- Founded
- PLUG 1997
- KROS 2015
- Country
- PLUG United States
- KROS United States
- Employees
- PLUG N/A
- KROS N/A
- Industry
- PLUG Industrial Machinery/Components
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- PLUG Energy
- KROS Health Care
- Exchange
- PLUG Nasdaq
- KROS Nasdaq
- Market Cap
- PLUG 1.6B
- KROS 558.9M
- IPO Year
- PLUG 1999
- KROS 2020
- Fundamental
- Price
- PLUG $1.40
- KROS $13.41
- Analyst Decision
- PLUG Hold
- KROS Buy
- Analyst Count
- PLUG 16
- KROS 13
- Target Price
- PLUG $1.76
- KROS $20.63
- AVG Volume (30 Days)
- PLUG 101.5M
- KROS 606.6K
- Earning Date
- PLUG 08-07-2025
- KROS 08-06-2025
- Dividend Yield
- PLUG N/A
- KROS N/A
- EPS Growth
- PLUG N/A
- KROS N/A
- EPS
- PLUG N/A
- KROS 0.11
- Revenue
- PLUG $642,224,000.00
- KROS $214,713,000.00
- Revenue This Year
- PLUG $17.73
- KROS $5,006.76
- Revenue Next Year
- PLUG $26.15
- KROS N/A
- P/E Ratio
- PLUG N/A
- KROS $122.43
- Revenue Growth
- PLUG N/A
- KROS 91657.70
- 52 Week Low
- PLUG $0.69
- KROS $9.12
- 52 Week High
- PLUG $3.34
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- PLUG 61.57
- KROS 42.34
- Support Level
- PLUG $1.09
- KROS $13.25
- Resistance Level
- PLUG $1.57
- KROS $13.99
- Average True Range (ATR)
- PLUG 0.14
- KROS 0.39
- MACD
- PLUG 0.02
- KROS -0.06
- Stochastic Oscillator
- PLUG 68.52
- KROS 22.49
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.